APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adrenocorticotropic Hormone Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Adrenocorticotropic Hormone Receptor Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchAdrenocorticotropic Hormone Receptor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Adrenocorticotropic Hormone Receptor Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Adrenocorticotropic Hormone Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adrenocorticotropic Hormone Receptor Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Adrenocorticotropic Hormone Receptor Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Adrenocorticotropic Hormone Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Adrenocorticotropic Hormone Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Adrenocorticotropic Hormone Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adrenocorticotropic Hormone Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Adrenocorticotropic Hormone Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Adrenocorticotropic Hormone Receptor market include Pfizer Inc., XOMA Corporation, Retrophin Inc., Mallinckrodt Plc, Ipsen S.A. and Alder Biopharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Adrenocorticotropic Hormone Receptor market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Adrenocorticotropic Hormone Receptor and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Adrenocorticotropic Hormone Receptor revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Adrenocorticotropic Hormone Receptor market.

Adrenocorticotropic Hormone Receptor Segment by Company

Pfizer Inc.

XOMA Corporation

Retrophin Inc.

Mallinckrodt Plc

Ipsen S.A.

Alder Biopharmaceuticals Inc.

Adrenocorticotropic Hormone Receptor Segment by Type

Corticotropin

BIM-23B065

AQB-565

Others

Adrenocorticotropic Hormone Receptor Segment by Application

Acromegaly

Cushing Disease

Hormonal Disorder

Musculoskeletal Disorder

Others

Adrenocorticotropic Hormone Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Adrenocorticotropic Hormone Receptor status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Adrenocorticotropic Hormone Receptor key companies, revenue, market share, and recent developments.

3. To split the Adrenocorticotropic Hormone Receptor breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Adrenocorticotropic Hormone Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Adrenocorticotropic Hormone Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Adrenocorticotropic Hormone Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adrenocorticotropic Hormone Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adrenocorticotropic Hormone Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adrenocorticotropic Hormone Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adrenocorticotropic Hormone Receptor industry.

Chapter 3: Detailed analysis of Adrenocorticotropic Hormone Receptor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Adrenocorticotropic Hormone Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Adrenocorticotropic Hormone Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Adrenocorticotropic Hormone Receptor Industry Trends Table 2. Adrenocorticotropic Hormone Receptor Industry Drivers Table 3. Adrenocorticotropic Hormone Receptor Industry Opportunities and Challenges Table 4. Adrenocorticotropic Hormone Receptor Industry Restraints Table 5. Global Adrenocorticotropic Hormone Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Adrenocorticotropic Hormone Receptor Revenue Share by Company (2021-2026) Table 7. Global Adrenocorticotropic Hormone Receptor Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Adrenocorticotropic Hormone Receptor Key Company Manufacturing Base & Headquarters Table 9. Global Adrenocorticotropic Hormone Receptor Company, Product Type & Application Table 10. Global Adrenocorticotropic Hormone Receptor Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Adrenocorticotropic Hormone Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Corticotropin Table 15. Significant Companies of BIM-23B065 Table 16. Significant Companies of AQB-565 Table 17. Significant Companies of Others Table 18. Global Adrenocorticotropic Hormone Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Adrenocorticotropic Hormone Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Adrenocorticotropic Hormone Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Type (2021-2026) Table 22. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Acromegaly Table 24. Significant Companies of Cushing Disease Table 25. Significant Companies of Hormonal Disorder Table 26. Significant Companies of Musculoskeletal Disorder Table 27. Significant Companies of Others Table 28. Global Adrenocorticotropic Hormone Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Adrenocorticotropic Hormone Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Adrenocorticotropic Hormone Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Application (2021-2026) Table 32. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Application (2027-2032) Table 33. Global Adrenocorticotropic Hormone Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Adrenocorticotropic Hormone Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Region (2021-2026) Table 36. Global Adrenocorticotropic Hormone Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Region (2027-2032) Table 38. Global Adrenocorticotropic Hormone Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Adrenocorticotropic Hormone Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Adrenocorticotropic Hormone Receptor Sales Value Market Share by Country (2021-2026) Table 41. Global Adrenocorticotropic Hormone Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Adrenocorticotropic Hormone Receptor Sales Value Market Share by Country (2027-2032) Table 43. Pfizer Inc. Company Information Table 44. Pfizer Inc. Business Overview Table 45. Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Pfizer Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 47. Pfizer Inc. Recent Development Table 48. XOMA Corporation Company Information Table 49. XOMA Corporation Business Overview Table 50. XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. XOMA Corporation Adrenocorticotropic Hormone Receptor Product Portfolio Table 52. XOMA Corporation Recent Development Table 53. Retrophin Inc. Company Information Table 54. Retrophin Inc. Business Overview Table 55. Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Retrophin Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 57. Retrophin Inc. Recent Development Table 58. Mallinckrodt Plc Company Information Table 59. Mallinckrodt Plc Business Overview Table 60. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product Portfolio Table 62. Mallinckrodt Plc Recent Development Table 63. Ipsen S.A. Company Information Table 64. Ipsen S.A. Business Overview Table 65. Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ipsen S.A. Adrenocorticotropic Hormone Receptor Product Portfolio Table 67. Ipsen S.A. Recent Development Table 68. Alder Biopharmaceuticals Inc. Company Information Table 69. Alder Biopharmaceuticals Inc. Business Overview Table 70. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product Portfolio Table 72. Alder Biopharmaceuticals Inc. Recent Development Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Adrenocorticotropic Hormone Receptor Product Image Figure 2. Global Adrenocorticotropic Hormone Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adrenocorticotropic Hormone Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Adrenocorticotropic Hormone Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Corticotropin Image Figure 8. BIM-23B065 Image Figure 9. AQB-565 Image Figure 10. Others Image Figure 11. Global Adrenocorticotropic Hormone Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Adrenocorticotropic Hormone Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Type (2021-2032) Figure 14. Acromegaly Image Figure 15. Cushing Disease Image Figure 16. Hormonal Disorder Image Figure 17. Musculoskeletal Disorder Image Figure 18. Others Image Figure 19. Global Adrenocorticotropic Hormone Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Adrenocorticotropic Hormone Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Application (2021-2032) Figure 22. Global Adrenocorticotropic Hormone Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Adrenocorticotropic Hormone Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Adrenocorticotropic Hormone Receptor Sales Value (2021-2032) & (US$ Million) Figure 25. North America Adrenocorticotropic Hormone Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Adrenocorticotropic Hormone Receptor Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Adrenocorticotropic Hormone Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Adrenocorticotropic Hormone Receptor Sales Value (2021-2032) & (US$ Million) Figure 31. South America Adrenocorticotropic Hormone Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Adrenocorticotropic Hormone Receptor Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Adrenocorticotropic Hormone Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Corticotropin
  • BIM-23B065
  • AQB-565
  • Others
Applications
  • Acromegaly
  • Cushing Disease
  • Hormonal Disorder
  • Musculoskeletal Disorder
  • Others
Companies covered
  • Pfizer Inc.
  • XOMA Corporation
  • Retrophin Inc.
  • Mallinckrodt Plc
  • Ipsen S.A.
  • Alder Biopharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Adrenocorticotropic Hormone Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Adrenocorticotropic Hormone Receptor Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Adrenocorticotropic Hormone Receptor Market Dynamics
  1. 2.1 Adrenocorticotropic Hormone Receptor Industry Trends
  2. 2.2 Adrenocorticotropic Hormone Receptor Industry Drivers
  3. 2.3 Adrenocorticotropic Hormone Receptor Industry Opportunities and Challenges
  4. 2.4 Adrenocorticotropic Hormone Receptor Industry Restraints
3 Adrenocorticotropic Hormone Receptor Market by Company
  1. 3.1 Global Adrenocorticotropic Hormone Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Adrenocorticotropic Hormone Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Adrenocorticotropic Hormone Receptor Company Ranking (2024-2026)
  4. 3.4 Global Adrenocorticotropic Hormone Receptor Company Manufacturing Base and Headquarters
  5. 3.5 Global Adrenocorticotropic Hormone Receptor Company Product Type and Application
  6. 3.6 Global Adrenocorticotropic Hormone Receptor Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Adrenocorticotropic Hormone Receptor Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Adrenocorticotropic Hormone Receptor Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Adrenocorticotropic Hormone Receptor Market by Type
  1. 4.1 Adrenocorticotropic Hormone Receptor Type Introduction
  2. 4.1.1 Corticotropin
  3. 4.1.2 BIM-23B065
  4. 4.1.3 AQB-565
  5. 4.1.4 Others
  6. 4.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Type
  7. 4.2.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Type (2021-2032)
  9. 4.2.3 Global Adrenocorticotropic Hormone Receptor Sales Value Share by Type (2021-2032)
5 Adrenocorticotropic Hormone Receptor Market by Application
  1. 5.1 Adrenocorticotropic Hormone Receptor Application Introduction
  2. 5.1.1 Acromegaly
  3. 5.1.2 Cushing Disease
  4. 5.1.3 Hormonal Disorder
  5. 5.1.4 Musculoskeletal Disorder
  6. 5.1.5 Others
  7. 5.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Application
  8. 5.2.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Application (2021-2032)
  10. 5.2.3 Global Adrenocorticotropic Hormone Receptor Sales Value Share by Application (2021-2032)
6 Adrenocorticotropic Hormone Receptor Regional Value Analysis
  1. 6.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Region (2021-2032)
  3. 6.2.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Region: 2021-2026
  4. 6.2.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Adrenocorticotropic Hormone Receptor Sales Value (2021-2032)
  7. 6.3.2 North America Adrenocorticotropic Hormone Receptor Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Adrenocorticotropic Hormone Receptor Sales Value (2021-2032)
  10. 6.4.2 Europe Adrenocorticotropic Hormone Receptor Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Adrenocorticotropic Hormone Receptor Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Adrenocorticotropic Hormone Receptor Sales Value (2021-2032)
  16. 6.6.2 South America Adrenocorticotropic Hormone Receptor Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Adrenocorticotropic Hormone Receptor Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Adrenocorticotropic Hormone Receptor Sales Value Share by Country, 2025 VS 2032
7 Adrenocorticotropic Hormone Receptor Country-level Value Analysis
  1. 7.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Country (2021-2032)
  3. 7.2.1 Global Adrenocorticotropic Hormone Receptor Sales Value by Country (2021-2026)
  4. 7.2.2 Global Adrenocorticotropic Hormone Receptor Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Adrenocorticotropic Hormone Receptor Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Adrenocorticotropic Hormone Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Adrenocorticotropic Hormone Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer Inc.
  2. 8.1.1 Pfizer Inc. Company Information
  3. 8.1.2 Pfizer Inc. Business Overview
  4. 8.1.3 Pfizer Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  6. 8.1.5 Pfizer Inc. Recent Developments
  7. 8.2 XOMA Corporation
  8. 8.2.1 XOMA Corporation Company Information
  9. 8.2.2 XOMA Corporation Business Overview
  10. 8.2.3 XOMA Corporation Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  11. 8.2.4 XOMA Corporation Adrenocorticotropic Hormone Receptor Product Portfolio
  12. 8.2.5 XOMA Corporation Recent Developments
  13. 8.3 Retrophin Inc.
  14. 8.3.1 Retrophin Inc. Company Information
  15. 8.3.2 Retrophin Inc. Business Overview
  16. 8.3.3 Retrophin Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Retrophin Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  18. 8.3.5 Retrophin Inc. Recent Developments
  19. 8.4 Mallinckrodt Plc
  20. 8.4.1 Mallinckrodt Plc Company Information
  21. 8.4.2 Mallinckrodt Plc Business Overview
  22. 8.4.3 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mallinckrodt Plc Adrenocorticotropic Hormone Receptor Product Portfolio
  24. 8.4.5 Mallinckrodt Plc Recent Developments
  25. 8.5 Ipsen S.A.
  26. 8.5.1 Ipsen S.A. Company Information
  27. 8.5.2 Ipsen S.A. Business Overview
  28. 8.5.3 Ipsen S.A. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ipsen S.A. Adrenocorticotropic Hormone Receptor Product Portfolio
  30. 8.5.5 Ipsen S.A. Recent Developments
  31. 8.6 Alder Biopharmaceuticals Inc.
  32. 8.6.1 Alder Biopharmaceuticals Inc. Company Information
  33. 8.6.2 Alder Biopharmaceuticals Inc. Business Overview
  34. 8.6.3 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alder Biopharmaceuticals Inc. Adrenocorticotropic Hormone Receptor Product Portfolio
  36. 8.6.5 Alder Biopharmaceuticals Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst